RxDoctor Payments Data

Kevin Choe, MD

Radiation Oncology · Fairfax, VANPI 1609043892

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,732 of the $7,732 with a category attached, or 74.1%. 21 manufacturers reported payments, led by Novocure Inc. at 32.9% of the total. Among radiation oncology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,732in general payments, 2019–2025

Across 65 payments — averaging $118.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novocure Inc.$3K
  • Bioprotect Medical, Inc.$2K
  • Boston Scientific$543
  • GT Medical Technologies, Inc$371
  • Elekta, Inc.$349
  • Isoray, Inc$289
  • plus $2K from 15 others
$7,100in research payments, 2019–2025

Across 1 payment — averaging $7100.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$7K

What the payments were for

  • Consulting fees$2,00026%
  • Food & beverage$5,73274%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,732 in reported general payments places this provider in the 90th percentile of 121 radiation oncology providers in Virginia.

See all radiation oncology providers in Virginia

Medicare billing

Part B allowed, 2024
$357,744
Medicare patients
660
Services billed
3,302

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl53$598

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Fairfax

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →